Article in Heart (British Cardiac Society), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04577716 (The PET-EVAR Study - Predicting Endoleaks Following Endovascular Aortic Aneurysm Repair Using 18F-Sodium Fluoride), which is not on this map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 30% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Samuel DebonoBritish Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK samuel.debono@ed.ac.uk.ORCID 0000-0002-7834-8766
Jennifer NashBritish Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK.
Alexander J FletcherBritish Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK.
Maaz SyedBritish Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK.
Edwin J R van BeekBritish Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK.
Michelle Claire WilliamsBritish Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK.ORCID 0000-0003-3556-2428
Orwa FalahThe Edinburgh Vascular Service, Royal Infirmary of Edinburgh, NHS Lothian, Edinburgh, UK.
Andrew TambyrajaThe Edinburgh Vascular Service, Royal Infirmary of Edinburgh, NHS Lothian, Edinburgh, UK.
Marc R DweckBritish Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK.
David E NewbyBritish Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK.ORCID 0000-0001-7971-4628
Rachael O ForsytheBritish Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK.
British Heart Foundation · GBNHS Lothian · GB
Funding
British Heart Foundation FS/18/31/33676British Heart Foundation FS/19/15/34155British Heart Foundation FS/ICRF/20/26002British Heart Foundation FS/SCRF/21/32010British Heart Foundation PG/21/10461British Heart Foundation RE/18/5/34216Chief Scientist Office ETM/365Wellcome TrustWellcome Trust WT103782AIA
6 · The paper itself
Abstract
objectiveIn patients with abdominal aortic aneurysms, sodium [
methodsIn a preliminary proof-of-concept cohort study, preoperative and post-operative sodium [
resultsTen participants were recruited (76±6 years) with a mean aortic diameter of 57±2 mm at time of EVAR. Mean time from EVAR to repeat scan was 62±21 months. Prior to EVAR, there was higher abdominal aortic AMA when compared with the thoracic aorta (AMA 1.88 vs 1.2; p<0.001). Following EVAR, sodium [
conclusionsEVAR is associated with a reduction in AMA within the stented aortic segment. This suggests that EVAR can modify aortic disease activity and aortic sodium [
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.